SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
Rebecca Johnson,1 Nirupama Sabnis,2 Xiangle Sun,1 Ruhani Ahluwalia,3 Andras G Lacko2,4 1Institute of Molecular Medicine, 2Institute for Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center, 3Harmony School of Innovation, 4Department of Pediatrics, University of Nort...
Enregistré dans:
Auteurs principaux: | Johnson R, Sabnis N, Sun X, Ahluwalia R, Lacko AG |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f7262946c78546ec9f27e10edded8f4c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
par: Sabnis S, et autres
Publié: (2017) -
Filamin-A expression in triple-negative breast cancer and its clinical significance
par: Abderrahman Ouban
Publié: (2021) -
An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
par: Xiaowei Wang, et autres
Publié: (2021) -
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
par: Manvi Sharma, et autres
Publié: (2021) -
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
par: Purwanto I, et autres
Publié: (2021)